M. Miravitlles (Barcelona (CT), Spain), M. Barrecheguren Fernandez (Barcelona, Spain), N. Roche (Paris, France)
Including the ALERT sessions (Abstracts Leading to Evolution in
Respiratory Medicine Trials), these formats showcase important and very late-breaking clinical trial data from all respiratory disease areas. Presenters, session chairs and viewers will take part lively discussions on the presented trials.
RCT Abstract - The efficacy and safety of colistimethate sodium delivered via the I-neb in bronchiectasis: the PROMIS-I randomized controlled trial C. Haworth (Cambridge, United Kingdom), M. Shteinberg (Haifa, Israel), K. Winthrop (Portland, United States of America), F. Blasi (Milan, Italy), K. Dimakou (Athens, Greece), L. Morgan (Sydney, Australia), F. Ringshausen (Hannover, Germany), O. Vidal (Barcelona, Spain), R. Thompson (Brisbane, Australia), K. Sharp (Farnborough, United Kingdom), I. Vissers (Bresso, Italy), D. Hull (Chichester (West Sussex), United Kingdom), J. Chalmers (Dundee, United Kingdom)
|    |
Exposure-response relationships of brensocatib in patients with non-cystic fibrosis bronchiectasis (NCFBE) C. Fernandez (Bridgewater, United States of America), C. Rubino (Schenectady, United States of America), A. Teper (Bridgewater, United States of America), H. Usansky (Bridgewater, United States of America), J. Chalmers (Dundee, United Kingdom), K. Mange (Bridgewater, United States of America)
|    |
Wrap-up by discussant and discussion H. Keir (Dundee (Angus), United Kingdom)
|   |
Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial S. Ramakrishnan (Oxford, United Kingdom), D. Nicolau Jr (Oxford, United Kingdom), B. Langford (Oxford, United Kingdom), M. Mahdi (Oxford, United Kingdom), H. Jeffers (Oxford, United Kingdom), C. Mwasuku (Oxford, United Kingdom), K. Krassowska (Oxford, United Kingdom), R. Fox (Bicester, United Kingdom), I. Binnian (Eynsham, United Kingdom), V. Glover (Faringdon, United Kingdom), S. Bright (Witney, United Kingdom), C. Butler (Oxford, United Kingdom), J. Cane (Oxford, United Kingdom), A. Halner (Oxford, United Kingdom), P. Matthews (Oxford, United Kingdom), L. Donnelly (London, United Kingdom), J. Simpson (Newcastle, New South Wales, Australia), J. Baker (London, United Kingdom), N. Fadai (Nottingham, United Kingdom), S. Peterson (Lund, Sweden), T. Bengtsson (Lund, Sweden), P. Barnes (London, United Kingdom), R. Russell (Oxford, United Kingdom), M. Bafadhel (Oxford, United Kingdom)
|    |
RCT Abstract - An adaptive randomized controlled trial of non-invasive respiratory strategies in acute respiratory failure patients with COVID-19 B. Connolly (Belfast, United Kingdom), G. Perkins (Coventry, United Kingdom), C. Ji (Coventry, United Kingdom), K. Couper (Coventry, United Kingdom), R. Lall (Coventry, United Kingdom), J. Baillie (Midlothian, United Kingdom), J. Bradley (Belfast, United Kingdom), P. Dark (Manchester, United Kingdom), C. Dave (Birmingham, United Kingdom), A. De Soyza (Newcastle Upon Tyne, United Kingdom), A. Dennis (Birmingham, United Kingdom), A. Devrell (Coventry, United Kingdom), S. Fairbairn (Cwmbran, United Kingdom), H. Ghani (Watford, United Kingdom), E. Gorman (Belfast, United Kingdom), C. Green (Birmingham, United Kingdom), N. Hart (London, United Kingdom), S. Hee (Coventry, United Kingdom), Z. Kimbley (Birmingham, United Kingdom), S. Madathil (Birmingham, United Kingdom), N. Mcgowan (Coventry, United Kingdom), B. Messer (Newcastle Upon Tyne, United Kingdom), J. Naisbitt (Bury, United Kingdom), C. Norman (Coventry, United Kingdom), D. Parekh (Birmingham, United Kingdom), E. Parkin (Bury, United Kingdom), J. Patel (Birmingham, United Kingdom), S. Regan (Coventry, United Kingdom), C. Ross (Sunderland, United Kingdom), A. Rostron (Sunderland, United Kingdom), M. Saim (Birmingham, United Kingdom), A. Simonds (London, United Kingdom), E. Skilton (Coventry, United Kingdom), N. Stallard (Coventry, United Kingdom), M. Steiner (Leicester, United Kingdom), R. Vancheeswaran (Watford, United Kingdom), J. Yeung (Coventry, United Kingdom), D. Mc Auley (Belfast, United Kingdom), On Behalf Of The Recovery-Rs Collaborators
|    |
Wrap-up by discussant and discussion G. Rohde (Frankfurt am Main, Germany)
|   |